You are viewing: Australia Cannabis Testing Market analysis
Part of: Cannabis Testing Market (Global)

The Australia Cannabis Testing Market was valued at $9.6 Million in 2024 and projected to reach to $18.4 Million by 2029, representing a compound annual growth rate of 13.8%. Australia's cannabis testing market is positioned for sustained growth as the country strengthens its regulatory infrastructure around medicinal cannabis.

Australia Cannabis Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Cannabis Testing Market Trends and Insights

  • This expansion reflects Australia's evolving regulatory framework and increasing adoption of medicinal cannabis products across the healthcare sector.
  • Australia's market growth is driven by stricter quality assurance requirements and heightened consumer awareness regarding product safety and potency verification. The cannabis testing landscape in Australia is characterized by rising demand for laboratory services that ensure compliance with therapeutic goods standards.
  • Australia's regulatory environment continues to support market expansion through enhanced testing protocols and certification requirements.
  • Between 2024 and 2029, Australia is expected to see accelerated investment in testing infrastructure and analytical capabilities to meet growing market demands..

Key Market Statistics

  • CAGR (2024-2029) 13.8% CAGR
  • Market Size, 2024 ~USD 9.6 Million
  • Forecast, 2029 ~USD 18.4 Million
  • Country Australia

Australia Cannabis Testing Market Overview

Market Valuation Growth :

Australia's cannabis testing market is valued at $9.6 million in 2024, with projections reaching $18.4 million by 2029, representing a robust 13.8% CAGR over the forecast period.

Regulatory Compliance Driver :

Stricter quality assurance requirements and evolving regulatory frameworks in Australia are compelling cannabis producers and distributors to invest in comprehensive testing solutions.

Medicinal Cannabis Adoption :

Increasing adoption of medicinal cannabis products across Australia's healthcare sector is driving demand for reliable testing services to ensure product safety and efficacy.

Consumer Confidence Impact :

Heightened consumer awareness and demand for quality assurance in Australia are pushing market participants to implement rigorous testing protocols and certifications.

Australia Cannabis Testing Market Dynamics

  • The 13.8% CAGR reflects increasing investments by testing laboratories and service providers to meet compliance standards and quality benchmarks.
  • Healthcare providers and pharmaceutical companies are expanding their cannabis product portfolios, necessitating comprehensive testing capabilities. The market outlook remains positive with anticipated regulatory clarity and potential expansion of medicinal cannabis access.
  • Testing service providers are expected to enhance their capabilities in potency analysis, microbial testing, and residue detection.
  • As Australia's healthcare sector continues to integrate cannabis-based therapeutics, demand for accredited testing facilities will intensify, supporting market expansion through 2029..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Australia's cannabis testing market is valued at $9.6 million in 2024 with a projected CAGR of 13.8% through 2029.
    • Australia's regulatory framework mandates comprehensive testing for potency, contaminants, and microbial safety in medicinal cannabis products.
    • Australia's market growth is supported by increasing therapeutic cannabis prescriptions and stricter therapeutic goods administration compliance requirements.
    • Australia's testing infrastructure is expanding to accommodate rising demand from licensed producers and healthcare providers seeking quality assurance.

    Cannabis Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment POTENCY TESTING SERVICES (Service)
    Forecast Period 2024-2029
    Growth Rate CAGR of 17.2% from 2024 to 2029
    Largest Segment PRODUCTS (Product & Software)
    Market Size Base Year (Billions) ~USD 1.81 (2024)
    Revenue Forecast (Billions) ~USD 4 (2029)
    Segments Covered Product & Software, Type, Service, End User, Component

    Australia Cannabis Testing Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product & Software

    • Products
    • Software

    By Type

    • Analytical Instruments
    • Atomic Spectroscopy Instruments
    • Chromatography Columns
    • Chromatography Instruments
    • Consumables
    • Gas Chromatography
    • Gas Chromatography Instruments
    • Large-Scale Laboratories
    • Liquid Chromatography
    • Liquid Chromatography Instruments
    • Mass Spectrometry Instruments
    • Medium-Scale Laboratories
    • Other Analytical Instruments
    • Other Chromatography Instruments
    • Other Consumables
    • Sample Preparation Products
    • Small-Scale Laboratories
    • Spectroscopy Instruments
    • Standards & Crms

    By Service

    • Heavy Metal Testing Services
    • Microbial Analysis Services
    • Other Cannabis Testing Services
    • Pesticide Screening Services
    • Potency Testing Services
    • Residual Solvent Analysis Services
    • Terpene Profiling Services

    By End User

    • Cannabis Cultivators/Growers
    • Cannabis Drug Manufacturers & Dispensaries
    • Cannabis Testing Laboratories
    • Product & Software End Users
    • Research Institutes
    • Service End Users

    By Component

    • Products
    • Service
    • Software

    AUSTRALIA: CANNABIS TESTING SERVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    CANNABIS CULTIVATORS/GROWERS1.872.082.282.582.963.444.014.6715.4
    CANNABIS DRUG MANUFACTURERS & DISPENSARIES9.9711.2512.5314.3916.8119.8123.4627.7817.3
    TOTAL11.8413.3214.8116.9719.7723.2527.4732.4517

    AUSTRALIA: CANNABIS TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    PRODUCT & SOFTWARE END USERS9.4910.3111.0712.2513.7915.6517.8520.3512.9
    SERVICE END USERS11.8413.3214.8116.9719.7723.2527.4732.4517
    TOTAL21.3323.6425.8829.2233.5638.945.3152.815.3

    Target Audience

    • Cannabis Testing Laboratories : Testing facilities need Australia-specific market data to understand growth opportunities, competitive positioning, and regulatory requirements essential for expanding service offerings and capacity planning.
    • Medicinal Cannabis Producers : Producers require detailed market insights on testing standards and compliance requirements in Australia to ensure product quality, meet regulatory obligations, and build consumer trust.
    • Healthcare & Pharmaceutical Companies : Healthcare providers and pharmaceutical firms need market intelligence on testing capabilities and regulatory pathways to integrate cannabis products into their therapeutic portfolios effectively.
    • Investment & Venture Capital Firms : Investors seeking Australia cannabis sector opportunities need comprehensive market data, growth projections, and competitive analysis to evaluate investment viability and portfolio allocation.
    • Regulatory & Compliance Consultants : Consultants advising cannabis businesses require Australia-specific market and regulatory insights to guide clients through compliance requirements and quality assurance implementation strategies.

    Reasons to Buy this Report

    • Market Size & Growth Trajectory : Access precise valuation data for Australia's cannabis testing market with detailed CAGR analysis, enabling accurate financial forecasting and investment decision-making for the 2024-2029 period.
    • Regulatory Landscape Intelligence : Understand Australia's evolving regulatory framework and quality assurance requirements that directly impact testing service demand, helping stakeholders align operations with compliance standards.
    • Competitive Positioning Strategy : Identify market opportunities and growth drivers specific to Australia's healthcare sector adoption of medicinal cannabis, enabling service providers to optimize their market entry and expansion strategies.
    • Consumer Demand Insights : Gain actionable intelligence on Australian consumer confidence trends and quality expectations driving testing service adoption, supporting product development and marketing initiatives.
    • Investment & Partnership Opportunities : Leverage comprehensive Australia-specific market data to identify high-potential partnerships, acquisition targets, and investment opportunities within the cannabis testing ecosystem.

    Frequently asked questions

    What is the current size of Australia's cannabis testing market?

    Australia's cannabis testing market was valued at $9.6 million in 2024 and is expected to grow to $18.4 million by 2029.

    What is the projected growth rate for Australia's cannabis testing market?

    Australia's cannabis testing market is projected to grow at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

    What regulatory requirements drive testing demand in Australia?

    Australia's Therapeutic Goods Administration mandates rigorous testing for cannabinoid potency, pesticide residues, heavy metals, and microbial contaminants in all medicinal cannabis products.

    Which testing services are most critical in Australia's market?

    Australia's market prioritizes potency analysis, residual solvent testing, microbial contamination screening, and heavy metal detection to ensure product safety and compliance.

    How is Australia's cannabis testing market expected to evolve by 2029?

    Australia's market is expected to see increased laboratory capacity, adoption of advanced analytical technologies, and expansion of accredited testing facilities to support growing medicinal cannabis demand.

    RESEARCH METHODOLOGY

    This study involved four major activities in estimating the current size of the cannabis testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the cannabis testing market. The secondary sources used for this study include the International Cannabis and Cannabinoids Institute (ICCI), Association of Commercial Cannabis Laboratories (ACCL), American Medical Marijuana Association (AMMA), California Cannabis Industry Association (CCIA), Oregon Cannabis Association (OCA), Canadian National Medical Marijuana Association (CNMMA), World Health Organization (WHO), National Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH), American Oil Chemists’ Society (AOCS), Association of Public Health Laboratories (APHL), American Association for Clinical Chemistry (AACC), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, News Articles, Journals, Press Releases, Paid Databases, Expert Interviews, and MarketsandMarkets Analysis, among others. These sources were also used to obtain key information about major players, global product revenues, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data was collected and analyzed to arrive at the overall size of the global cannabis testing market, which was validated through primary research.

    Primary Research

    In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

    Cannabis testing Market Size, and Share

    Note: Tiers are defined based on a company’s total revenue. As of 2023, Tier 1 = >USD 1 Bn, Tier 2 = USD 500 Mn to USD 1 Bn, and Tier 3 <USD 500 Mn.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The global size of the cannabis testing market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The major players in the industry and market have been identified through extensive primary and secondary research.
    • The cannabis testing-related business shares of leading players have been determined through secondary research and primary analysis.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Market Size Estimation Methodology-Bottom-up approach

    Cannabis testing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach-

    Cannabis testing Market Size, and Share

    Data Triangulation

    After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Cannabis raw material testing is crucial to quality assurance and regulatory compliance within the cannabis industry. It involves a comprehensive suite of analytical tests, products, and software to assess the safety, potency, and purity of cannabis plants or plant-derived materials before they are utilized in production processes. The key tests involved in cannabis testing include potency analysis, microbial screening, residual solvent testing, heavy metal analysis, pesticide residue testing, moisture content determination, terpene profiling, and foreign material inspection. The key products involved in cannabis testing include analytical and spectroscopy instruments, consumables, and software.

    Key Stakeholders

    • Cannabis Testing Product Manufacturing Companies
    • Regulatory Authorities
    • Cannabis Producers/Cultivators
    • Research & Development Companies
    • Biotechnology Companies
    • Research Laboratories & Academic Institutes.
    • Market Research & Consulting Firms
    • Testing Laboratories

    The main objectives of this study are as follows:

    • To define, describe, and forecast the cannabis testing market by product & software, service, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cannabis testing market
    • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and analyze their market shares and core competencies2
    • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions.
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report with additional efforts:

    • Product, Software & Service-Level Information
    • Country-wise Information:  Analysis for additional countries (up to five)
    • Company Information:  Detailed analysis and profiling of additional key market players across the globe

    Get the Full Cannabis Testing Market Report

    Full forecast, segment splits, and company analysis for all Cannabis Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status